⌘K

Login Start Free

Home/Filings/4/0001104659-22-001619

4//SEC Filing

MCNAB JAMES R 4

Accession 0001104659-22-001619

CIK 0000910267other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:52 PM ET

Size

5.1 KB

Accession

0001104659-22-001619

Insider Transaction Report

Form 4

Period: 2022-01-05

TITAN PHARMACEUTICALS INCTTNP

Director

Transactions

Award
Option to Purchase Common Stock
2022-01-05+10,000→ 10,000 total
Exercise: $1.18From: 2022-07-05Exp: 2032-01-05→ Common Stock (10,000 underlying)

Documents

1 file

4
tm221868-3_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

TITAN PHARMACEUTICALS INC

CIK 0000910267

Entity typeother

Related Parties

1

filerCIK 0001190126

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 6:52 PM ET
Size: 5.1 KB

View on SEC.gov